2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Jennifer S. Petschauer, PharmD

Drug Development/Clinical Research Fellow
University of North Carolina at Chapel Hill
101 Manning Drive
Chapel Hill, NC
USA 27514

Papers:
367 Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer